Journal article
Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma
Abstract
PURPOSE: To determine the health-related quality of life (QOL) during and after neoadjuvant chemoradiation therapy and surgery for patients with pancreatic adenocarcinoma.
METHODS AND MATERIALS: Participants of a prospective, phase 2 multi-institutional trial treated with neoadjuvant chemoradiation followed by surgery completed QOL questionnaires (European Organization for Research and Treatment in Cancer Quality of Life Questionnaire version …
Authors
Serrano PE; Herman JM; Griffith KA; Zalupski MM; Kim EJ; Bekaii-Saab TS; Ben-Josef E; Dawson LA; Ringash J; Wei AC
Journal
International Journal of Radiation Oncology • Biology • Physics, Vol. 90, No. 2, pp. 270–277
Publisher
Elsevier
Publication Date
October 2014
DOI
10.1016/j.ijrobp.2014.05.053
ISSN
0360-3016
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdenocarcinomaAdultAgedAged, 80 and overAntineoplastic AgentsChemoradiotherapyDeoxycytidineFemaleHealth StatusHumansMaleMiddle AgedNeoadjuvant TherapyOrganoplatinum CompoundsOxaliplatinPancreatectomyPancreatic NeoplasmsPatient ComplianceProspective StudiesQuality of LifeRadiotherapy, ConformalGemcitabine